Healthcare innovations, driven by advancements in clinical pharmacology, are being introduced at an unprecedented pace. Smaller drug innovator organizations rely on contract development and manufacturing organizations (CDMOs) for the capabilities they lack, and this is an intentional business model to keep their operations lean and cost-effective. But what happens when supply chains are impacted by logistics, difficult-to-find clinical trial materials, expensive APIs, or even a worldwide pandemic?
In this edition of "Adjusting Your Supply Chain for Success," we examine innovative ways of doing things, from accelerating the start of a new project to how service providers can help CFOs in pharma companies controlled by private equity. Supply chain optimizations sets a more efficient path for tech transfers, drug repurposing, and project kick-off, and, thus, end-to-end project success.